"Ocular Hypotension" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally low intraocular pressure often related to chronic inflammation (uveitis).
Below are MeSH descriptors whose meaning is more general than "Ocular Hypotension".
Below are MeSH descriptors whose meaning is more specific than "Ocular Hypotension".
This graph shows the total number of publications written about "Ocular Hypotension" by people in this website by year, and whether "Ocular Hypotension" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Ocular Hypotension" by people in Profiles.
Chu TC, Potter DE. Ocular hypotension induced by electroacupuncture. J Ocul Pharmacol Ther. 2002 Aug; 18(4):293-305.
Crosson CE. Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action. Invest Ophthalmol Vis Sci. 2001 Jul; 42(8):1837-40.
Potter DE, Ogidigben MJ, Chu TC. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. Pharmacology. 1998 Nov; 57(5):249-60.
Chu TC, Socci RR, Ogidigben MJ, Potter DE. Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. J Ocul Pharmacol Ther. 1997 Dec; 13(6):489-96.
Chu TC, Wong W, Gluchowski C, Hughes BW, Potter DE. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50.
Campbell WR, Potter DE. Potential role of imidazoline (I1) receptors in modulating aqueous humor dynamics. J Ocul Pharmacol. 1994; 10(1):393-402.
Crosson CE, Gray T. Modulation of intraocular pressure by adenosine agonists. J Ocul Pharmacol. 1994; 10(1):379-83.
Ogidigben M, Chu TC, Potter DE. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther. 1993 Nov; 267(2):822-7.
Chu TC, Ogidigben M, Han JC, Potter DE. Allicin-induced hypotension in rabbit eyes. J Ocul Pharmacol. 1993; 9(3):201-9.
Crosson CE. Ocular hypotensive activity of the adenosine agonist (R)-phenylisopropyladenosine in rabbits. Curr Eye Res. 1992 May; 11(5):453-8.